The Pharmaceutical Marketing Group

The best articles from selected authors of the pharma community.

  • Home
  • Login
More

    10 Things I Learned About Digital Health in Brazil

    I wrote this from the perspective of the entrepreneurs I met, currently forging digital health solutions in Brazil, and where I see the opportunities...

    Search for your favorite author

    Podcast: Trends in The New Value-Based Reimbursement Model

    Steve

    Amy

    Natalie

    Gary

    this month featured authors

    or click on the right to get a complete list of authors

    Continue to the category

    10 Things I Learned About Digital Health in Brazil

    I wrote this from the perspective of the entrepreneurs I met, currently forging digital health solutions in Brazil, and where I see the opportunities...

    Five Essential Skills for Pharma’s Future Leaders

    By Steve Figman, Syntegrity The recent eyeforpharma ‘19 conference in Philadelphia showcased an impressive array of speakers, with presentations and roundtable discussions from thought leaders...

    “Magic Mushrooms” for Psychotherapy—What Does the Evidence Say?

    What are “Magic Mushrooms”? “Magic mushrooms,” also known as “shrooms” among many other names, are mushrooms containing the hallucinogen psilocybin. This compound is found in...

    Top Tips – Building your ISO Quality Management System

    Top tips for building your ISO Quality Management System for Pharmaceutical Companies A Quality Management System (QMS) is key for pharma companies and should encourage...

    Importance of Patient Engagement and Empowerment for Pharma

    Except for direct participation in clinical trials and post-approval activities such as disease education, patient involvement in the biopharmaceutical development process remains episodic and...

    Connecting in the Digital Age

    Connecting in the Digital Age How Pharmaceutical Companies Can Use Marketing Outreach to Better Engage with Global Consumers By Guillem Vidal, Welocalize Life Sciences, lifesciences.welocalize.com Most companies...

    Why Too Many Clinical Trials Fail

    By Julien Moussalli Market Expansion Lead at IQVIA (LinkedIn: https://www.linkedin.com/in/julien-moussalli-80010349/) A makeover of the $65 billion clinical trials market (1) is well overdue. According to...

    Medical Marijuana and Cannabinoids for Cancer Therapy

    Medical marijuana – or cannabis – is one of the hottest topics in oncology right now. This is especially true as more and more...

    The digital game changers in pharma are not digital tools, but new aspirations

    Patient centricity, agility and digital capabilities are now the focus of many pharmaceutical companies to evolve one of the must important industries of our...

    Clinical Integration for Improving Healthcare

    As a result of rising healthcare costs, there have been widespread efforts to reform healthcare delivery worldwide. To succeed in this, many hospitals, health...

    Brexit Checklist for the Pharma Industry

    by John Cahill Director/Snr Consultant, Quality and Compliance A disorderly Brexit is moving from a possibility to a probability. While governments pass last minute legislation over the...

    A Pharmaceutical Launch Opportunity:​ Science, Art or Alchemy?

    A publisher friend recently suggested I write down what I knew about launching pharmaceutical brands, to help new marketers who may have been handed...

    Editor´s Pick

    180FollowersFollow
    15,000FollowersFollow
    2,503FollowersFollow

    U.S. judge appoints Ken Feinberg mediator for Bayer Roundup settlement talks

    A U.S. judge on Wednesday appointed prominent attorney Kenneth Feinberg as mediator for court-mandated settlement talks in the federal litigation over allegations that Bayer AG's glyphosate-based Roundup weed killer caused cancer.

    Novartis CEO plans gene therapy price ‘far lower’ than $4 million to $5 million range

    Novartis AG's top executive said on Wednesday it expects to price its gene therapy for spinal muscular atrophy “far lower” than the $4 million to $5 million figure the Swiss drugmaker has said it could be worth.

    Novartis has 25 blockbusters in the pipeline: CEO

    Novartis has 25 potential blockbuster treatments in development, the company said ahead of a management event in the United States on Thursday.

    PG&E wins court approval to set up $105 million wildfire assistance fund

    PG&E Corp may set up a $105 million housing fund for victims of 2017 and 2018 wildfires in California, which set records for devastation and were blamed on the utility's equipment, the judge overseeing the bankruptcy of the investor-owned power producer ruled on Wednesday.

    Senator Gillibrand wants insurance to pay for fertility treatments

    U.S. Democratic presidential hopeful Kirsten Gillibrand on Wednesday proposed requiring insurance companies to cover expensive fertility treatments, part of a "Family Bill of Rights" that would also help with adoption and medical care.

    More evidence welding fumes raise lung cancer risk

    (Reuters Health) - Workers exposed to welding fumes are more likely to develop lung cancer than those not exposed to the fumes, and a new study suggests this holds true regardless of other risk factors like smoking or exposure to asbestos.

    Vaccine doubts spread like disease, must be taken offline: vaccine chief

    Doubts about vaccines have spread across social media like a disease and false information that "kills people" should be taken down by the companies running digital platforms, the head of global vaccine alliance Gavi said on Tuesday.

    Array BioPharma’s colorectal cancer combo treatment meets main goals

    Array BioPharma Inc's cocktail of three therapies helped patients with a type of colorectal cancer live longer than those on standard treatment, according to interim results of a late-stage study on Tuesday.

    Merck’s Keytruda fails as monotherapy in breast cancer study

    Merck & Co Inc said on Monday its blockbuster cancer drug Keytruda failed to meet the main goal of a late-stage study testing the drug as a standalone treatment in patients with an aggressive type of breast cancer.

    Supreme Court gives Merck another shot to avoid Fosamax lawsuits

    The U.S. Supreme Court on Monday gave Merck & Co a new opportunity to avoid lawsuits accusing the company of failing to properly warn patients of debilitating thigh-bone fractures from taking its osteoporosis drug Fosamax, throwing out a lower court decision that had revived the litigation.

    South Africa’s Aspen sells Australian prescription portfolio to Mylan

    Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

    U.S. FDA labels J&J surgical staplers’ recall as severest

    The U.S. Food and Drug Administration warned of risks of serious injury or death from surgical staplers made by Johnson & Johnson's Ethicon unit, labeling a recent recall of the device as its most serious.

    AbbVie halts enrollment after brain cancer trial misses goal, shares fall

    AbbVie Inc said on Friday it has halted enrollment of patients in all ongoing studies testing its brain cancer treatment after the drug failed to meet the main goal in a late-stage trial.

    Look Who’s On the Move!

    180FollowersFollow
    15,000FollowersFollow
    2,503FollowersFollow

    Global Healthcare Strategy Consulting Expert Sheldon Ng Joins Navigant to Bolster Life Sciences and...

    CHICAGO--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24NCI&src=ctag" target="_blank"gt;$NCIlt;/agt;--Navigant (NYSE: NCI) today announced that Sheldon Ng has joined the firm as a managing director in its life sciences practice....

    Sotera Wireless Welcomes New Chief Operating Officer

    SAN DIEGO--(BUSINESS WIRE)--Sotera Wireless Welcomes New Chief Operating Officer http://www.businesswire.com/news/home/20190522005178/en/Sotera-Wireless-Welcomes-New-Chief-Operating-Officer/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    BioTime Announces Appointment of General Counsel

    ALAMEDA, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank"gt;$BTXlt;/agt; lt;a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank"gt;#AMDlt;/agt;--BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing cellular therapies for unmet medical...

    Indee Labs Announces Formation of Strategic Advisory Board

    BERKELEY, Calif. & SYDNEY--(BUSINESS WIRE)--Indee Labs Strategic Advisory Board Includes Six Globally-Recognised Experts in Microfluidics and Chimeric-antigen Receptor T-cells. http://www.businesswire.com/news/home/20190522005101/en/Indee-Labs-Announces-Formation-Strategic-Advisory-Board/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    Preston W. Campbell, President and CEO of the Cystic Fibrosis Foundation to Retire; Michael...

    BETHESDA, Md.--(BUSINESS WIRE)--Today the Cystic Fibrosis Foundation announced that President and CEO Preston W. Campbell, MD, plans to retire at the end of 2019....

    Seattle Genetics Appoints Robin Taylor, Ph.D., Chief Commercial Officer

    BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics appoints first Chief Commercial Officer, Robin G. Taylor, M.B.A., Ph.D. http://www.businesswire.com/news/home/20190521005064/en/Seattle-Genetics-Appoints-Robin-Taylor-Ph.D.-Chief/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    Karen Midthun, M.D., Joins Greenleaf Health

    WASHINGTON--(BUSINESS WIRE)--Greenleaf Health announces that former FDA Center Director Karen Midthun, M.D. has joined the firm as Principal, Drug & Biological Products. http://www.businesswire.com/news/home/20190521005453/en/Karen-Midthun-M.D.-Joins-Greenleaf-Health/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    FSD Pharma Welcomes All-Star Lineup of Cannabis Researchers to Scientific Advisory Board

    TORONTO--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/FSDDF?src=hash" target="_blank"gt;#FSDDFlt;/agt;--FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company"), is pleased to announce that three eminent cannabis...

    BioCatch Appoints Bill Sytsma as Chief Revenue Officer

    NEW YORK--(BUSINESS WIRE)--BioCatch, the global leader in AI-driven behavioral biometrics, today announced that Bill Sytsma has joined the company as Chief Revenue Officer. Sytsma...

    Certara Appoints Dr. William F. Feehery as Chief Executive Officer

    PRINCETON, N.J.--(BUSINESS WIRE)--Certara announced today that it has appointed Dr. William F. Feehery as its new CEO and a member of the Certara Board...

    Research and Development

    180FollowersFollow
    15,000FollowersFollow
    2,503FollowersFollow

    Pharma Jobs Site

    Here, worldwide, recruiters will be able to post their jobs and job seekers will be able to seek them.

    Pharma Guide Website

    Your industry meeting point. Add your business for free!

    Promising Clinical Data from Pilot Study of Gelesis’ Novel Hydrogel...

    BOSTON--(BUSINESS WIRE)--Gelesis announced the presentation of data from a clinical study of GS500 for potential treatment of chronic constipation at Digestive Disease Week. http://www.businesswire.com/news/home/20190519005027/en/Promising-Clinical-Data-Pilot-Study-Gelesis%E2%80%99-Hydrogel/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of...

    STAMFORD, Conn.--(BUSINESS WIRE)--SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat in Adult Patients with Desmoid Tumors http://www.businesswire.com/news/home/20190520005231/en/SpringWorks-Therapeutics-Announces-Initiation-Phase-3-Trial/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    Epizyme Announces New Tazemetostat Clinical Data to be Presented in...

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme Announces New Tazemetostat Clinical Data to be Presented in Oral Sessions at Multiple Upcoming Medical Meetings http://www.businesswire.com/news/home/20190516005652/en/Epizyme-Announces-New-Tazemetostat-Clinical-Data-Presented/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    Verastem Oncology to Present New COPIKTRA™ (Duvelisib) Dose Modification Data...

    BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and...

    GRAIL Announces Promising New Data with Early Detection Blood Test...

    MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, Inc., a healthcare company focused on the early detection of cancer, today announced that new findings from its Circulating Cell-free...

    ImmunoGen Announces Mature Data from FORWARD II Expansion Cohort Evaluating...

    WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced mature...

    EMMAC Presents to Scientific Committee (CSST) in Paris on Company’s...

    LONDON--(BUSINESS WIRE)--EMMAC Life Sciences Ltd (“EMMAC” or the “Company”), the European independent medical cannabis company, announces that on Wednesday 15th May, the Company presented...

    Dicerna Announces Dosing of First Patient in Phase 1 Clinical...

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna today announced the dosing of the first patient in its Phase 1 clinical trial of DCR-HBVS for the treatment of chronic...

    IMV to Present New Data at 2019 ASCO Annual Meeting...

    DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that the American Society of Clinical Oncology (ASCO)...

    Sensorion Announces the Positive Data Safety Monitoring Board (DSMB) Review...

    MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biopharmaceutical company which specializes in the development of novel therapies to restore,...

    GenSight Biologics Reports Positive 96-Week Data from REVERSE Phase III...

    PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for...

    InteRNA and UMC Utrecht Publish Preclinical Evidence for Potential of...

    UTRECHT, Netherlands--(BUSINESS WIRE)--InteRNA Technologies announced today the recent publication of data from a collaboration with University Medical Center (UMC) Utrecht in Journal of Neuroscience...

    Regulatory Affairs

    180FollowersFollow
    15,000FollowersFollow
    2,503FollowersFollow

    Gore Receives FDA Approval for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL

    FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Gore Receives FDA Approval for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL ...

    Genentech’s Personalized Medicine Entrectinib Shrank Tumors Harboring NTRK, ROS1 or...

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive data from...

    ImmunoGen Provides Regulatory Update on Mirvetuximab Soravtansine Monotherapy in Ovarian...

    WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced the...

    FDA Grants Orphan Drug Designation to Ayala’s AL101 for Potential...

    REHOVOT, Israel & WILMINGTON, Del.--(BUSINESS WIRE)--Ayala Pharmaceuticals, a clinical-stage company developing medicines for cancers that are genetically defined, announced today that...

    FDA Approves Broadened Indication for XEOMIN® (IncobotulinumtoxinA) as First-Line Treatment...

    RALEIGH, N.C.--(BUSINESS WIRE)--Merz Americas announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application...

    FDA Approves Impella 5.0 and Impella LD Extended Duration of...

    DANVERS, Mass.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/heartrecovery?src=hash" target="_blank"gt;#heartrecoverylt;/agt;--Abiomed announces the U.S. FDA has approved the expansion of the Impella 5.0 and Impella LD PMA...

    Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA...

    SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to POMALYST® (pomalidomide) for...

    Transgene receives FDA IND Clearance for Lead myvac™ Individualized Immunotherapy,...

    STRASBOURG, France--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/TG4050?src=hash" target="_blank"gt;#TG4050lt;/agt;--Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the...

    U.S. Food & Drug Administration Accepts Takeda’s Biologics License Application...

    OSAKA, Japan--(BUSINESS WIRE)--FDA has accepted for review a BLA for a subcutaneous formulation of Entyvio for maintenance therapy in adults with moderately to severely...

    Trividia Health, Inc. Announces Launch of TRUE A-G Scan™

    FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health Inc. announced today the launch of the TRUE A-G Scan™. The new product was presented this...

    FBI Approves Verogen’s Next-Gen Forensic DNA Technology for National DNA...

    SAN DIEGO--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/fbi?src=hash" target="_blank"gt;#fbilt;/agt;--The FBI has approved Verogen's groundbreaking next-gen forensic DNA technology for upload to the National DNA Index System (NDIS). http://www.businesswire.com/news/home/20190502005888/en/FBI-Approves-Verogen%E2%80%99s-Next-Gen-Forensic-DNA-Technology/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    22nd Century’s Pre-Market Tobacco Application for VLN™ Cigarettes Advances with...

    WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)--22nd Century’s PMT Application Advances with Completed FDA Inspection; Inspection is important milestone for 22nd Century's VLN™ Cigarettes ...

    FDA Authorizes Sale of IQOS Tobacco Heating System in the...

    RICHMOND, Va.--(BUSINESS WIRE)--FDA Authorizes Sale of IQOS Tobacco Heating System in the U.S. ...

    Triumvira Submits Investigational New Drug (IND) Application to the FDA...

    AUSTIN, Texas & HAMILTON, Ontario--(BUSINESS WIRE)--Triumvira submits IND to FDA and CTA to Health Canada to initiate a Phase 1/2, first-in-human trial of its...

    Advanced Sterilization Products Receives 510(k) Clearance for 22-Minute Automatic Endoscope...

    IRVINE, Calif.--(BUSINESS WIRE)--Advanced Sterilization Products (ASP) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...

    Co-Diagnostics, Inc. Files Provisional Patent for Simplified Targeted NGS Library...

    SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. Files Provisional Patent for Simplified Targeted NGS Library Preparation ...

    Industry News

    180FollowersFollow
    15,000FollowersFollow
    2,503FollowersFollow

    Verily Forms Strategic Alliances with Novartis, Otsuka, Pfizer and Sanofi...

    SAN FRANCISCO--(BUSINESS WIRE)--Verily forms strategic alliances with Novartis, Otsuka, Pfizer & Sanofi to develop digitally innovative, patient-centered clinical research programs. http://www.businesswire.com/news/home/20190521005485/en/Verily-Forms-Strategic-Alliances-Novartis-Otsuka-Pfizer/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==

    Quanterix Announces $50,000 in Grants to Support Promising Oncology Research

    LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced a call for proposals...

    meltmedia receives Inc.’s 2019 Best Workplaces Award

    TEMPE, Ariz.--(BUSINESS WIRE)--meltmedia receives Inc.’s 2019 Best Workplaces Award http://www.businesswire.com/news/home/20190516005008/en/meltmedia-receives-Inc.%E2%80%99s-2019-Workplaces-Award/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    EVER Pharma acquires Amneal Deutschland GmbH and extends its commercial...

    SALZBURG, Austria--(BUSINESS WIRE)--EVER Pharma Holding Ges.m.b.H (Austria) announced today that it has completed the acquisition of Amneal Deutschland GmbH, a subsidiary of Amneal Pharmaceuticals...

    Virta Health Partners with U.S. Department of Veterans Affairs to...

    SAN FRANCISCO--(BUSINESS WIRE)--Virta Health Partners with the U.S. Department of Veterans Affairs to Help Veterans Reverse Type 2 Diabetes http://www.businesswire.com/news/home/20190516005299/en/Virta-Health-Partners-U.S.-Department-Veterans-Affairs/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==

    Exelixis and Iconic Therapeutics Enter into Exclusive Option and License...

    ALAMEDA, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into an exclusive option and license agreement...

    PatientFi® Announces Study Partnership with Allergan

    IRVINE, Calif.--(BUSINESS WIRE)--PatientFi, LLC, a leading financial technology company that partners with medical practices to offer patients accessible financing plans for elective procedures, is...

    Mercer Park Brand Acquisition Corp. Lists on NEO

    TORONTO--(BUSINESS WIRE)--Mercer Park Brand Acquisition Corp. Class A Restricted Voting Units will begin trading today on NEO under the symbol BRND.U http://www.businesswire.com/news/home/20190513005465/en/Mercer-Park-Brand-Acquisition-Corp.-Lists-NEO/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    Walgreens Boots Alliance Announces Collaboration for Cancer Prevention, Research and...

    DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced today the launch of its Collaboration for Cancer Prevention, Research and Support. http://www.businesswire.com/news/home/20190513005256/en/Walgreens-Boots-Alliance-Announces-Collaboration-Cancer-Prevention/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    Adlon Therapeutics L.P. to Provide Funding Opportunities for Research to...

    STAMFORD, Conn.--(BUSINESS WIRE)--Adlon Therapeutics L.P. to Provide Funding Opportunities for Research to Expand Understanding of ADHD http://www.businesswire.com/news/home/20190513005237/en/Adlon-Therapeutics-L.P.-Provide-Funding-Opportunities-Research/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    Award-Winning Actor and Producer Sterling K. Brown Joins Bristol-Myers Squibb in...

    NEW YORK--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24BMY&src=ctag" target="_blank"gt;$BMYlt;/agt; lt;a href="https://twitter.com/hashtag/BMS?src=hash" target="_blank"gt;#BMSlt;/agt;--Award-Winning Actor and Producer Sterling K. Brown Joins Bristol-Myers Squibb in Effort to Share Stories of What...

    Masimo and Mindray Announce Expanded Partnership

    NEUCHATEL, Switzerland & SHENZHEN, China--(BUSINESS WIRE)--Masimo and Mindray have entered into a purchase and license agreement under which Mindray will offer Masimo SET® in...

    Exelixis’ Collaborator Daiichi Sankyo Launches MINNEBRO® (Esaxerenone) Tablets in Japan

    ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced its partner Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) has launched MINNEBRO® (esaxerenone) tablets as a treatment...

    ElevateBio Launches to Create and Operate a Portfolio of Highly...

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--ElevateBio Launches to Create and Operate a Portfolio of Highly Innovative Cell and Gene Therapy Companies http://www.businesswire.com/news/home/20190513005224/en/ElevateBio-Launches-Create-Operate-Portfolio-Highly-Innovative/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    ICON Awarded Clinical Research Team of the Year and Best...

    DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today announced...

    Phone number:

    (+54911) 62650005

    Working hour:

    Mon - Frid: 09:00 - 17:00 EST

    E-mail us:

    info@pharmamkt.net